Fieldpoint Private Securities, LLC Neurocrine Biosciences Inc Transaction History
Fieldpoint Private Securities, LLC
- $344 Million
- Q2 2022
A detailed history of Fieldpoint Private Securities, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 1,046 shares of NBIX stock, worth $138,218. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,046
Previous 1,088
3.86%
Holding current value
$138,218
Previous $102,000
-0.0%
% of portfolio
0.03%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding NBIX
# of Institutions
650Shares Held
96.9MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.88 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.31 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$731 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$642 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$353 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.6B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...